HDAC1 and neoplasm: Baicalein inhibited the activities of HDAC-1 and HDAC-8 and induced proteasomal degradation of HDAC-1, thereby suppressing tumor cell growth and differentiation in in vitro and in vivo models of acute myeloid leukemia [208].